‘I had no symptoms’: Leeds woman’s remarkable recovery after bowel cancer diagnosis
Julie had the shock diagnosis just after her 60th birthday
A Leeds woman who was diagnosed with bowel cancer despite having no symptoms has spoken of her remarkable recovery after taking part in a pioneering clinical trial.
Julie Viligiardi was diagnosed in July 2024, shortly after her 60th birthday, following a colonoscopy prompted by a routine bowel cancer screening test.
Having felt completely well, she was shocked to discover something was wrong and said she would never have known about the cancer without the national screening programme.


Now, after completed treatment and returning to the things she loves, Julie is urging others to take up screening invitations and consider clinical trials where possible.
She said: “I didn’t expect anything to be wrong because I felt completely well. I’d just come back from a holiday abroad and there was nothing that would have made me go to the doctor.
“Without the screening test, I wouldn’t have known anything was wrong.”
When she received the diagnosis, Julie's first thoughts were for her adult daughter, who has autism and relies heavily on her support.
“I feared what would happen if I wasn’t able to care for her,” she said.
“She’s an adult but she’s still very dependent on me. That was my biggest worry. It wasn’t really about me at all.”
Soon after her diagnosis, Julie met Dr James Platt, a medical oncology specialty registrar at Leeds Teaching Hospitals NHS Trust and clinical research fellow at the University of Leeds.
He reassured her that her cancer could be treated and offered her the opportunity to take part in FOxTROT 3, an innovative bowel cancer clinical trial funded by Yorkshire Cancer Research.


The trial, led by researchers at the universities of Leeds and Birmingham, is investigating whether a more intensive chemotherapy treatment using three drugs instead of two can improve outcomes for younger and fitter patients.
It builds on earlier research which found that giving chemotherapy before surgery can reduce surgical complications and the risk of cancer returning.
After discussing her options, Julie decided to take part.
She said: “When he explained the trial to me, it just made sense. Having chemotherapy first to shrink the tumour, then surgery, followed by more treatment to clear anything that might be left felt like the best possible approach.”


Julie began chemotherapy in October 2024.
She added: “Losing my hair was traumatic at the time, but I was completely focused on getting well.
“There were difficult days and some delays to my treatment because my blood counts dropped, but I always tried to focus on the bigger picture.”
On New Year's Eve, Julie underwent surgery to remove the tumour.
She had initially been warned that she might need a stoma bag, but was relieved to discover after the operation that this had not been necessary.


She said: “When I woke up after surgery, the first thing I did was check my stomach and realised there was no stoma.
“The surgeon came to see me and said everything had gone smoothly and the tumour had been successfully removed. It was such a relief.”
Following her recovery in hospital, Julie returned home before beginning further chemotherapy eight weeks later.
She completed her treatment in April 2025 and has since returned to enjoying life, spending time with her daughter and singing with the community choir she has been part of for more than 10 years.
Reflecting on her experience, Julie believes taking part in the trial gave her the best possible chance of recovery.
“I feel very lucky to have been given the opportunity to take part in a clinical trial,” Julie said.
“It gave me access to a different way of treating cancer that could make a real difference, not just for me, but for people in the future.”
Julie recently took part in Yorkshire Cancer Research's 2026 Christmas campaign, appearing in a fashion show alongside other people affected by cancer.
She wanted to give something back to the charity which funded the research she benefited from and help raise awareness of the importance of cancer research.
She said: “Taking part in the fashion show was something I never imagined doing, but it felt important to support the charity that helped fund the research I benefited from.”
Although Julie is grateful to have completed treatment, she admits the emotional impact of cancer does not simply disappear when treatment ends.
She said: “During treatment you’re so focused on getting through it that you don’t always stop to think about what’s happening. Afterwards, that’s when some of those thoughts catch up with you.
“At the same time, it does make you appreciate life differently. It makes you think about what’s important and how you want to spend your time.”
Now, she hopes her experience will encourage others to take bowel cancer screening seriously and consider the opportunities offered by clinical research.
She said: “I had no symptoms at all, so without screening, I wouldn’t have known anything was wrong. If my cancer had progressed to a later stage, I might never have had the opportunity to take part in a clinical trial either.
“I feel very grateful for the care I received and for the opportunity to take part in research. It gives you hope things are improving and that better cancer treatments are being developed.”
